CAB39 and glioblastoma: Studies in Glioblastoma cellular proliferation and migration for both of these proteins identified the potential of therapeutically targeting miR-451 in order to inhibit cell growth and slow down cell migration through the blocking of the CAB39/AMPK pathway [52,53].